United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 24, 2026 · Filed Jun 25, 2026

On Jun 24, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$548.69 for US$5.21M under a trading plan, leaving 40,513 shares. Filed Jun 25, 2026 (Form 4).

Sold
9,500 shares
Price
US$548.69 average (US$545.93 to US$553.24)
Value
US$5.21M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 24, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jun 24, 2026Common StockSale760US$545.9349,253Direct
Jun 24, 2026Common StockSale2,234US$547.0347,019Direct
Jun 24, 2026Common StockSale2,086US$548.0144,933Direct
Jun 24, 2026Common StockSale1,300US$548.7443,633Direct
Jun 24, 2026Common StockSale1,357US$550.0642,276Direct
Jun 24, 2026Common StockSale1,003US$551.0341,273Direct
Jun 24, 2026Common StockSale360US$551.7640,913Direct
Jun 24, 2026Common StockSale400US$553.2440,513Direct

Source

View original at SEC

Related